NK cells specifically TCR-dressed to kill cancer cells

BACKGROUND: Adoptive T-cell transfer of therapeutic TCR holds great promise to specifically kill cancer cells, but relies on modifying the patient's own T cells ex vivo before injection. The manufacturing of T cells in a tailor-made setting is a long and expensive process which could be resolve...

Descripción completa

Detalles Bibliográficos
Autores principales: Mensali, Nadia, Dillard, Pierre, Hebeisen, Michael, Lorenz, Susanne, Theodossiou, Theodossis, Myhre, Marit Renée, Fåne, Anne, Gaudernack, Gustav, Kvalheim, Gunnar, Myklebust, June Helen, Inderberg, Else Marit, Wälchli, Sébastien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Research paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413353/
https://www.ncbi.nlm.nih.gov/pubmed/30665853
http://dx.doi.org/10.1016/j.ebiom.2019.01.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413353/
https://www.ncbi.nlm.nih.gov/pubmed/30665853
http://dx.doi.org/10.1016/j.ebiom.2019.01.031

Ejemplares similares